Since healthcare markets are experiencing significant cost constraints, providers may invest in innovative technologies that streamline specialty drug usage.
FERMONT, CA: More effective products and services, more efficient use of suppliers' capacities and other disruptive improvements in the reward system are seen as potential and beneficial outcomes of ongoing healthcare technological development. Technology-based applications from Avalon Healthcare Solutions tackle the cost associated with healthcare systems. Pharmacy costs in Avalon account for about 20 percent of the healthcare spending, and specialty drugs are estimated to account for more than 50 percent of that cost. Prior approval is an essential tool, but not adequate to deal effectively with the size and use of medical specialty drugs.
Medical Benefit Management Software (MBMS) is a cloud-based offering from Avalon, providing real-time medical editing and flexible claim management processes for health plans. The key Medical Benefit Management Software is used to improve outpatient laboratory facilities, saving up to 8 to 12 percent of outpatient laboratory spending on health plans. For medical specialty products, the company offers a second platform for providing clinical claims editing. Avalon's MBMS configures healthcare policies and edits to cover unnecessary items, vial optimization, usage off-label, and more.
The IT healthcare company, Avalon, targets to enable substantial savings from individual health plan offerings by automating existing adherence mechanisms. A series of evidence-based laboratory guidelines have also been established by an independent clinical advisory board addressing all aspects of laboratory testing. Using real-time technology, the company benefits the handling of high-volume, low-cost programs.